These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 14125108)

  • 21. INHIBITION OF FIBRINOLYSIS AND FIBRINOGENOLYSIS IN MAN: COMPARISON OF EPILSON-AMINOCAPROIC AID AND KALLIKREIN INHIBITOR.
    BECK E; SCHMUTZLER R; DUCKERT F
    Thromb Diath Haemorrh; 1963 Nov; 10():106-19. PubMed ID: 14081273
    [No Abstract]   [Full Text] [Related]  

  • 22. INTERACTION OF STREPTOKINASE AND HUMAN PLASMINOGEN. I. COMBINING OF STREPTOKINASE AND PLASMINOGEN OBSERVED IN THE ULTRACENTRIFUGE UNDER A VARIETY OF EXPERIMENTAL CONDITIONS.
    DAVIES MC; ENGLERT ME; DERENZO EC
    J Biol Chem; 1964 Aug; 239():2651-6. PubMed ID: 14235549
    [No Abstract]   [Full Text] [Related]  

  • 23. INHIBITION OF CASEINOLYTIC ACTIVITY OF PLASMIN BY VARIOUS SYNTHETIC INHIBITORS.
    MURAMATU M; ONISHI T; MAKINO S; FUJII S; YAMAMURA Y
    J Biochem; 1965 Mar; 57():402-6. PubMed ID: 14326097
    [No Abstract]   [Full Text] [Related]  

  • 24. SOME PROPERTIES OF THE ANTIFIBRINOLYTICALLY ACTIVE ISOMER OF AMINO-METHYLCYCLOHEXANE CARBOXYLIC ACID.
    DUBBER AH; MCNICOL GP; DOUGLAS AS; MELANDER B
    Lancet; 1964 Dec; 2(7373):1317-9. PubMed ID: 14224037
    [No Abstract]   [Full Text] [Related]  

  • 25. [EXISTENCE OF CHANGES IN HEMOSTASIS WITH DECREASED FIBRINOLYSIS. BASIS FOR THE HEMOSTATIC TREATMENT WITH EPSILON AMINOCAPROIC ACID IN NON FIBRINOLYTIC HEMORRHAGIC DIATHESIS].
    CASTILLO R; SERRANO J; CARALPS A; VINAS M
    Med Clin (Barc); 1963 Oct; 41():302-6. PubMed ID: 14125259
    [No Abstract]   [Full Text] [Related]  

  • 26. A RAPID SCREENING METHOD FOR DEMONSTRATING FIBRINOLYSIS DURING SURGICAL OPERATIONS.
    BOTTEMA JK; VERVOORT HJ
    Clin Chim Acta; 1964 Feb; 9():179-82. PubMed ID: 14122507
    [No Abstract]   [Full Text] [Related]  

  • 27. A METHOD FOR ASSESSING CLOT LYSIS.
    HOWELL M
    J Clin Pathol; 1964 May; 17(3):310-2. PubMed ID: 14159468
    [No Abstract]   [Full Text] [Related]  

  • 28. [ACTION OF EPSILON-AMINO CAPROIC ACID ON BLEEDING IN URINARY SURGERY].
    ABOULKER P; LASSNER J; SAMAMA M; CASUBOLO
    Anesth Analg (Paris); 1963; 20():581-95. PubMed ID: 14048694
    [No Abstract]   [Full Text] [Related]  

  • 29. STUDIES ON THE MOLECULAR PATHOLOGY AND PATHOGENESIS OF BLEEDING IN SEVERE FIBRINOLYTIC STATES IN DOGS.
    KOWALSKI E; BUDZYNSKI AZ; KOPEC M; LATALLO ZS; LIPINSKI B; WEGRZYNOWICZ Z
    Thromb Diath Haemorrh; 1964 Oct; 12():69-86. PubMed ID: 14224647
    [No Abstract]   [Full Text] [Related]  

  • 30. THE STREPTOKINASE ACTIVATION OF HUMAN PLASMINOGEN. DIRECT ANALYSIS OF THE ACTIVATION MIXTURE.
    RIFE U; SHULMAN S
    Thromb Diath Haemorrh; 1963 Nov; 10():133-45. PubMed ID: 14081275
    [No Abstract]   [Full Text] [Related]  

  • 31. STREPTOKINASE AND PULMONARY EMBOLISM.
    BROWSE NL; JAMES DC
    Lancet; 1964 Nov; 2(7368):1039-43. PubMed ID: 14206016
    [No Abstract]   [Full Text] [Related]  

  • 32. A STANDARD CLOT METHOD FOR THE ASSAY OF PLASMINOGEN ACTIVATORS, ANTI-ACTIVATORS, AND PLASMIN.
    HAWKEY CM; STAFFORD JL
    J Clin Pathol; 1964 Mar; 17(2):175-81. PubMed ID: 14149945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. STUDIES ON THE ACTIVATION OF PLASMINOGEN. II. ON THE NATURE OF THE PROACTIVATOR.
    GUTMAN M; RIMON A
    Can J Biochem; 1964 Sep; 42():1339-45. PubMed ID: 14217241
    [No Abstract]   [Full Text] [Related]  

  • 34. THE FORMATION OF CHONDROMUCOPROTEIN-FIBRINOGEN AND CHONDROMUCOPROTEIN-BETA-LIPOPROTEIN COMPLEXES.
    ANDERSON AJ
    Biochem J; 1963 Sep; 88(3):460-9. PubMed ID: 14071519
    [No Abstract]   [Full Text] [Related]  

  • 35. [EFFECT OF FIBRINOLYTIC ACTION FOUND IN ASCITES OF EHRLICH CANCER CELL IN MICE].
    HIRATA T
    Kobe Ika Daigaku Kiyo; 1963 Dec; 25():1-9. PubMed ID: 14117791
    [No Abstract]   [Full Text] [Related]  

  • 36. [COMPARATIVE STUDY ON THE EFFECT OF EPSILON-AMINOCAPROIC ACID, ACETYL-EPSILON-AMINOCAPROIC ACID AND CAPROLACTAM FOR VARIOUS PARAMETERS OF THE FIBRINOLYTIC SYSTEM].
    AUERSWALD W; DOLESCHEL W
    Wien Med Wochenschr; 1965 Feb; 115():102-5. PubMed ID: 14260441
    [No Abstract]   [Full Text] [Related]  

  • 37. FIBRINOLYSIS AND THE PLASMA PROTEIN ELECTROPHORETIC PATTERN.
    BIELAWIEC M; NILSSON IM
    Scand J Clin Lab Invest; 1964; 16():513-20. PubMed ID: 14209211
    [No Abstract]   [Full Text] [Related]  

  • 38. HEPARIN FRACTIONATION IN THE STUDY OF LYTIC ACTIVITY.
    GREEN J
    J Clin Pathol; 1964 May; 17(3):316-8. PubMed ID: 14159470
    [No Abstract]   [Full Text] [Related]  

  • 39. [THERAPEUTIC FIBRINOLYSIS. I. STUDIES ON THE EFFECTS OF STREPTOKINASE AND ACTASE IN VITRO].
    JUERGENS J
    Klin Wochenschr; 1964 Jun; 42():534-8. PubMed ID: 14233281
    [No Abstract]   [Full Text] [Related]  

  • 40. POSTOPERATIVE CHANGES IN THE COAGULATION FACTORS AND THE FIBRINOLYTIC SYSTEM.
    OLOW B
    Scand J Clin Lab Invest; 1964; 16():SUPPL 78:30-3. PubMed ID: 14199706
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.